Target intelligence / Profile preview

Hydroxyapatite formation at the material-tissue interface

Molecular classification
Other
01

Overview

Hydroxyapatite formation at the material-tissue interface is a complex physicochemical and biological process essential for the integration of orthopedic and dental implants with host bone. It involves the precipitation of calcium and phosphate ions from physiological fluids onto the surface of a biomaterial, forming a carbonated hydroxyapatite layer that mimics the natural mineral phase of bone (Source: PubMed, PMID: 16454482). This layer facilitates the adsorption of adhesive proteins and the subsequent attachment, proliferation, and differentiation of osteoblasts, leading to a stable mechanical bond known as osseointegration (Source: NIH, StatPearls). While not a single protein or receptor, this interface is the primary site of action for bioactive coatings and bone-graft substitutes designed to treat bone defects and fractures. Therapeutic strategies often aim to accelerate this formation using growth factors like Bone Morphogenetic Proteins (BMPs) or by modifying the implant surface topography and chemistry (Source: Wikipedia, Hydroxyapatite). Failure to establish this interface can result in fibrous encapsulation and eventual implant loosening, while excessive or misplaced mineralization can lead to pathological calcification in soft tissues.

Other names
OsseointegrationBiomineralizationBioactivityApatite layer formationBone-implant interface mineralization
02

Mechanism of action

Promotion of mineral nucleation and growth, enhancement of osteoblast differentiation, and inhibition of bone resorption through binding to the mineral matrix.

03

Biological functions

BiomineralizationBone remodelingCell adhesionOsteogenesis
04

Disease associations

OsteoporosisBone fracturesOsteoarthritisImplant failureEctopic calcification
05

Safety considerations

Ectopic calcificationAseptic looseningForeign body responseStress shieldingOsteonecrosis of the jaw
06

Interacting drugs

Alendronate

5 more in the full profile.

07

Biomarkers

Alkaline phosphataseOsteocalcinProcollagen type I N-terminal propeptide (P1NP)Bone-specific alkaline phosphatase

Beyond the preview

Go deeper on Hydroxyapatite formation at the material-tissue interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite formation at the material-tissue interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call